News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool
Photo from medicinespatentpool.org
Jun 22, 2023, 18:35

Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool

Breaking | 4 generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis,’ nilotinib for the treatment of chronic myeloid leukaemia.
The four generic manufacturers companies include:

  1. Eugia Pharma Specialities Ltd (INDIA)
  2. Hetero (INDIA)
  3. Dr. Reddy’s Laboratories (INDIA)
  4. PT. Brightgene Biomedical Indonesia (INDONESIA)

 

Source:

cancer chronic myeloid leukaemia generic health for all India Indonesia Medicines Patent Pool nilotinib Novartis OncoDaily Pharma
Special Coverage
Blog
Nov 15, 2024, 21:44
Karen Humphreys won the Advocate of the Year from the Florida Society of Clinical Oncology - UF Health Cancer Center
Blog
Nov 15, 2024, 21:37
Margaret Foti: AACR Special Conference on Liquid Biopsy
Blog
Nov 15, 2024, 21:26
Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy
Blog
Nov 15, 2024, 21:21
Adjuvant immunotherapy in patients with resected GEJ cancer with high risk for recurrence
Blog
Nov 15, 2024, 21:09
Miriam Knoll: An in-person lung tumor board with Nagashree Seetharamu
Insight
Nov 15, 2024, 21:05
Get Ready for ESTRO2025 Pre-Meeting Courses
Insight
Nov 15, 2024, 21:03
Explore the latest in oncology at ESMOASIA24
Insight
Nov 15, 2024, 21:02
Robin Zon: Debate day 2 of COSA
Blog
Nov 15, 2024, 20:28
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
Blog
Nov 15, 2024, 19:31
What is proton beam therapy and how does it work - Atrium Health
Blog
Nov 15, 2024, 17:47
Nico Gagelmann: Current status and Future directions for CAR-T Therapy
Insight
Nov 15, 2024, 17:45
Osteopontin as a therapeutic target in Breast Cancer recurrence